UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011307
Receipt number R000013211
Scientific Title An evaluation of different suturing techniques using V-Loc180 in subcutaneous suture: Continuous vertical suture or Continuous horizontal suture ?
Date of disclosure of the study information 2013/08/01
Last modified on 2019/02/01 10:42:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An evaluation of different suturing techniques using V-Loc180 in subcutaneous suture: Continuous vertical suture or Continuous horizontal suture ?

Acronym

An evaluation of different suturing techniques using V-Loc180 in subcutaneous suture: Continuous vertical suture or Continuous horizontal suture ?

Scientific Title

An evaluation of different suturing techniques using V-Loc180 in subcutaneous suture: Continuous vertical suture or Continuous horizontal suture ?

Scientific Title:Acronym

An evaluation of different suturing techniques using V-Loc180 in subcutaneous suture: Continuous vertical suture or Continuous horizontal suture ?

Region

Japan


Condition

Condition

Patients who will receive a bilaterally symmetrical cut wound longer than or equal to 20 cm long on the trunk.

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Two different suturing techniques using the suture thread, V-Loc180, will be evaluated. In patients with a bilaterally symmetrical cut wound longer than or equal to 20 cm long on the trunk, half of the wound will be closed with continuous vertical sutures and the other half with continuous horizontal sutures, and the results of the suturing techniques will be compared.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

VSS (Vancouver Scar Scale)

Key secondary outcomes

1) POSAS (The Patient and Observer Scar Assessment Scale)
2) Operating time
3) Time needed to complete suturing
4) Length and number of suture threads used for suturing
5) Complications
6) Malfunctions


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

In patients with a bilaterally symmetrical cut wound longer than or equal to 20cm long on the trunk, continuous vertical sutures will be applied to half of the wound.

Interventions/Control_2

Continuous horizontal sutures will be applied to the other half.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who will receive a bilaterally symmetrical cut wound longer than or equal to 20 cm long on the trunk
2) Patients with an Eastern Cooperative Oncology Group Scale of Performance Status (ECOG) of either 0 or 1
3) Patients with sufficient function of the major organs
4) Written informed consent to participate in the trial must be obtained from the patient him/herself (those of 20 years or older) or the guardians (those under 20 years old).

Key exclusion criteria

1) Patients with past traumatic injury at the suture site
2) Patients with an active bacterial or fungal infection
3) Patients with poorly controlled diabetes mellitus (HbA1C>8.0)
4) Patients with psychiatric disorders or symptoms and for whom it is judged difficult to participate in the trial
5) Patients who are allergic to nickel chrome
6) Patients who are otherwise judged unsuitable to participate in the trial by the investigator

Target sample size

31


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Ohjimi

Organization

School of Medicine, Fukuoka University

Division name

Department of Plastic and Reconstructive Surgery

Zip code


Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka

TEL

092-801-1011

Email

ohjimi@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshihisa Kawakami

Organization

School of Medicine, Fukuoka University

Division name

Department of Plastic and Reconstructive Surgery

Zip code


Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka

TEL

092-801-1011

Homepage URL


Email

kawaprs@fukuoka-u.ac.jp


Sponsor or person

Institute

Department of Plastic and Reconstructive Surgery, School of Medicine, Fukuoka University

Institute

Department

Personal name



Funding Source

Organization

Covidien Japan Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福岡大学病院


Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 24 Day

Date of IRB


Anticipated trial start date

2013 Year 08 Month 02 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 04 Month 30 Day

Date trial data considered complete

2015 Year 05 Month 31 Day

Date analysis concluded

2015 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2013 Year 07 Month 29 Day

Last modified on

2019 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013211


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name